Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Pre-close Trading Statement

19 Jan 2012 07:00

RNS Number : 8058V
Biome Technologies PLC
19 January 2012
 



19 January 2012

 

 

Biome Technologies plc

("Biome" or "the Group")

 

Pre-close Trading Statement

 

 

Biome Technologies plc, the bioplastics and RF technology business, is providing a pre-close trading statement for the financial year ended 31 December 2011 ahead of the announcement of the audited Preliminary results.

 

The Board is pleased to report that it expects the financial performance of Biome for the full year period to be in line with its expectations. Group revenue for the full year exceeded that in 2010 by more than 40% and, as a consequence, a significant reduction in operating loss is anticipated.

 

In the Bioplastics Division, revenue growth has been encouraging with an increase in revenues across products, applications and geographies. This growth was particularly strong in the first half, with more moderate growth in the second half, due to some market volatility following the easing of previous supply chain constraints. Revenue growth was particularly robust in the wholly owned Biome Bioplastics business as the commercial and technological capability of the team continues to strengthen.

 

The Stanelco RF Technologies Division saw a further substantial improvement over the course of the year with the continuation of a sizeable fibre optic furnace build programme and additional diversification into new industrial markets.

 

The Group's cash position at 31 December 2011 was £2.4m (30 September 2011: £3.0m) and the Group's debt facility of up to £2.0m remains unutilised.

 

As Continental Europe remains a major part of the Group's operations, the Board remains mindful of the wider economic uncertainties that could impact Biome in 2012. However, against this backdrop, incoming order level for the Bioplastics Division is strong and the signing of the previously announced contract between the RF Technologies Division and Durapipe UK provides considerable encouragement for 2012.

 

The Board feels confident that the Group can continue delivering on its strategy and building a successful business.

 

The Group expects to publish its Preliminary results for the full year ended 31 December 2011 on 29 March 2012.

 

-Ends-

 

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer 

Declan Brown, Group Finance Director

Tel: +44 (0) 2380 867 100

 

Daniel Stewart & Company plc

David Hart (Nomad)

 

Tel: +44 (0) 20 7776 6550

FTI Consulting

Oliver Winters

Latika Shah

 

Tel: +44 (0) 20 7831 3113

First Columbus

Chris Crawford

Kelly Gardiner

Tel: +44 (0) 20 3002 2070

 

Notes to Editor:

Admitted to AIM in July 2010, the activities of Biome operate in two divisions; Biome Bioplastics and Stanelco RF Technologies. Both divisions are underpinned by the Group's skills in the commercialisation and development of innovative technology.

The Group's core strategy is to develop and broaden its bioplastics business organically and is engaged with a variety of large-scale international customers and partners on a number of key commercial and development partnerships. These target applications in the food, horticulture and the electronics markets, amongst others, further enhance the Group's existing and new product development.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDVLFFLFFZBBQ
Date   Source Headline
21st Mar 20257:00 amRNSCancellation- Biome Technologies PLC
13th Mar 202512:22 pmRNSResult of GM & update on Cancellation
21st Feb 20257:00 amRNSProposed Cancellation & Notice of GM
18th Dec 20247:00 amRNSSecured Funding Facility
4th Dec 20247:00 amRNSTrading Update and Board Change
13th Nov 20247:00 amRNSTrading Update
25th Oct 20247:00 amRNSAppointment of Non-Executive Director
30th Sep 20245:00 pmRNSTotal Voting Rights
30th Sep 202411:08 amRNSContract win for Stanelco RF Division
20th Sep 20247:00 amRNSInterim Results
13th Sep 202410:58 amRNSHolding(s) in Company
12th Sep 202411:43 amRNSHolding(s) in Company
11th Sep 20243:01 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSHolding(s) in Company
9th Sep 20244:51 pmRNSHolding(s) in Company
4th Sep 20242:39 pmRNSResult of General Meeting and TVR
30th Aug 20245:00 pmRNSTotal Voting Rights
23rd Aug 20242:42 pmRNSHolding(s) in Company
22nd Aug 202411:00 amRNSHolding(s) in Company
22nd Aug 20247:00 amRNSResult of Retail Offer, Director dealing and TVR
21st Aug 20244:12 pmRNSHolding(s) in Company
21st Aug 20241:41 pmRNSHolding(s) in Company
16th Aug 20247:05 amRNSRetail offer to raise up to £80,000
16th Aug 20247:01 amRNSProposed Fundraise and other matters
16th Aug 20247:00 amRNSTrading update
10th Jul 20247:00 amRNSDirectorate Change
8th Jul 20247:00 amRNSTrading update
12th Jun 20247:00 amRNSGrant of Options
29th May 202410:57 amRNSResult of AGM, Interim CFO and Directorate Change
22nd May 20242:27 pmRNSContract win for Stanelco RF Division
15th May 20247:00 amRNSNotice of AGM and 2023 Annual Report
29th Apr 20247:01 amRNSTrading Update
29th Apr 20247:00 amRNSFinal Results 2023
15th Mar 20247:00 amRNSContract win for Stanelco RF Division
11th Mar 20241:59 pmRNSIssue of Convertible Loan Notes, PDMR Notification
15th Feb 20242:54 pmRNSContract win for RF Division
6th Feb 20247:00 amRNSTrading Update
13th Nov 20237:00 amRNSTrading Update
10th Oct 20234:32 pmRNSGrant of Options
27th Sep 20237:00 amRNSInterim Results
26th Jul 20237:00 amRNSTrading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20237:00 amRNSContract win for Stanelco RF Division
31st May 20237:00 amRNSIssue of Equity, Director/PDMR Shareholding & TVR
25th May 20232:57 pmRNSAppointment of Non-Executive Director
25th May 202312:45 pmRNSResult of AGM
2nd May 20231:05 pmRNSDirector/PDMR Shareholding
27th Apr 20237:00 amRNSNotice of AGM and 2022 Annual Report
26th Apr 20237:01 amRNSTrading Update
26th Apr 20237:00 amRNSFinal Results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.